Puma Biotechnology Inc — balance (NASDAQ:PBYI) | MetaTrader

Ver el calendario completo

Financials

Visión general Informes Estadísticas

Activos totales 244.22 M226.59 M222.06 M230.53 M213.33 M216.3 M Total de pasivos 250.17 M229.03 M200.45 M177.09 M121.21 M85.96 M Capital total -5.95 M-2.45 M21.61 M53.44 M92.13 M130.34 M Total de pasivos y patrimonio neto 244.22 M226.59 M222.06 M230.53 M213.33 M216.3 M Deuda total 98.31 M97.09 M98.31 M99.66 M67.05 M22.52 M Deuda neta 4.92 M27.24 M51.76 M50.74 M-19.79 M-69.1 M

Puma Biotechnology Inc

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

Noticias

Editas (EDIT) Up 3.8% Since Last Earnings Report: Can It Continue?

Agios Pharmaceuticals (AGIO) Moves 14.3% Higher: Will This Strength Last?

Puma Biotechnology 4T 2025: ingresos de NERLYNX suben 15%

Puma Biotechnology reporta sólidos resultados del cuarto trimestre de 2025

Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why

IRWD vs. PBYI: Which Small-Cap Biotech Stock Is a Better Buy?

Puma Biotech en Conferencia TD Cowen: Crecimiento y Disciplina Financiera

PBYI Q4 Earnings & Sales Beat Estimates, Stock Down on Weak 2026 View

Puma Biotechnology, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:PBYI) 2026-02-27

Puma Biotech (PBYI) Q4 Earnings and Revenues Beat Estimates

Jazz Pharmaceuticals (JAZZ) Beats Q4 Earnings and Revenue Estimates

Exelixis (EXEL) Q4 Earnings and Revenues Beat Estimates